Psychosocial Stress Clinical Trial
Official title:
Biobehavioral Effects of Therapy Dog Visitation in Elderly Intensive Care Unit Patients: A Pilot and Feasibility Study
Verified date | November 2018 |
Source | The University of Texas Health Science Center, Houston |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to assess the preliminary efficacy of a 10-minute therapy dog visitation (TDV) in reducing biobehavioral stress responses.
Status | Completed |
Enrollment | 15 |
Est. completion date | February 26, 2018 |
Est. primary completion date | February 26, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - =50 years old - able to provide consent and understand English - able to complete study instruments Exclusion Criteria: - currently taking hormone replacement or steroidal anti-inflammatory medications, - in contact precautions at facility, - diagnosed with Addison's or Cushing's disease - fears or phobias to dogs, or allergies to dogs. |
Country | Name | City | State |
---|---|---|---|
United States | The University of Texas Health Science Center at Houston | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
The University of Texas Health Science Center, Houston | The Methodist Hospital System |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in stress as assessed by the Stress-Visual Analog Scale | Stress will be measured using the Stress-Visual Analog Scale which is a tool used in intensive care unit (ICU) settings that consists of a small, unmarked 100mm ruler with endpoints labeled "none" and "as bad as it could be". Participants indicate how stressed they feel on the ruler, which yields a single subjective stress score between 0 and 100. The Stress visual analogue scale (VAS) demonstrates acceptable validity between the VAS and the Hospital Anxiety and Depression (HADS) total score with correlations of r = 0.65. | immediately before TDV, immediately after TDV | |
Primary | Change in Anxiety as assessed by the Faces Anxiety Scale | Anxiety will be measured using the FACES Anxiety Scale, a brief single-item, five-point self-report scale commonly used in the ICU consisting of 5 faces representing an increased level of anxiety, where the first item represents a "no anxiety" face (Elkman & Friesen; 1975). The FACES Anxiety Scale is a commonly used instrument in the ICU and proposed by the American Association of Critical-Care Nurses and demonstrates acceptable criterion validity between the FACES Anxiety Scale and State Anxiety Inventory total score in ventilated and non-ventilated ICU patients with correlations of r =.70; p<0005. | immediately before TDV, immediately after TDV | |
Primary | Change in Mood as assessed by the Positive and Negative Affect Schedule | Measures for mood (positive/negative affect) will be measured using the Positive and Negative Affect Schedule (PANAS). The PANAS is an established 20-item instrument that uses a 5-point Likert scale and includes single words that express negative and positive moods. The instructions on the instrument would be revised to state, "indicate how you feel right now" rather than "indicate how you felt in the last week." Sample answers include "excited", "scared", "nervous", and "enthusiastic," etc. (Craword & Henry, 2004). | immediately before TDV, immediately after TDV | |
Primary | Change in biological stress response as assessed by salivary cortisol levels | Saliva samples will be assayed using standardized enzyme immunoassay (EIA) kits (Salimetrics, State Park: PA). For cortisol, intra-assay coefficient of variation (CV) ranges between 4%-7% and inter-assay CV ranges between 3%-11%. Sensitivity of the EIA kit is .0007 µg/mL. | immediately before TDV, immediately after TDV | |
Primary | Change in biological inflammatory stress responses as assessed by salivary C-reactive protein (CRP) levels | Saliva samples will be assayed using standardized enzyme immunoassay (EIA) kits (Salimetrics, State Park: PA). For CRP, intra-assay CV ranges between 1.9%-5.9% and inter-assay CV ranges between 3.7%-11.2%. Sensitivity of the EIA kit is 10 pg/mL. | immediately before TDV, immediately after TDV | |
Primary | Change in biological inflammatory stress responses as assessed by salivary interleukin-1beta (IL-1ß) levels | Saliva samples will be assayed using standardized enzyme immunoassay (EIA) kits (Salimetrics, State Park: PA). For IL-1ß, intra-assay CV ranges between 2-3% and inter-assay CV is 4.5%. Sensitivity of the EIA kit is 0.6 pg/mL. | immediately before TDV, immediately after TDV | |
Secondary | Attachment level to pets as assessed by the Pet Attitude Scale (PAS) | Attachment to pets will be measured using the Pet Attitude Scale (PAS) Questionnaire. The PAS is considered a reliable instrument in the elderly with a Cronbach's alpha of 0.73. | immediately before TDV | |
Secondary | Human-Animal Interaction as assessed by the Human-Animal Interaction Scale (HAIS) | The Human-Animal Interaction Scale (HAIS) is a newly developed questionnaire designed to measure behavioral interactions between animal and human which predict beneficial effects to humans (Fournier, Letson, Laitalia, & Krog, 2015). The HAIS is a 26 item Likert Scale with 5 Likert response statements ranging from "not at all" to "a great deal" and is completed by the participant after the TDV. | immediately after TDV | |
Secondary | Human-Animal Interaction as assessed by the HAIS observer questionnaire | The HAIS observer questionnaire is a 24 item instrument completed by the research staff who quantifies behaviors with a percent or range in respect to the behavior observed. | immediately after TDV |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03017027 -
Effects of Animal Assisted Activity on Biobehavioral Stress Responses of Hospitalized Children: A Randomized Control Trial
|
N/A | |
Recruiting |
NCT01445015 -
Stress Management Intervention in Inner City Adolescents With Asthma
|
Phase 2 | |
Withdrawn |
NCT02002780 -
Recognizing and Treating Psychosocial Stress Among Children With Complex Heart Problems
|
Phase 2 | |
Recruiting |
NCT04324190 -
DIgital Online SuPport for COVID-19 StrEss
|
N/A |